Clinical trial
Vascular Closure With Novel External Compression Device After Atrial Fibrillation Ablation: The LockeT Study
NCT06199414 is registered in ClinicalTrials.gov with Kansas City Heart Rhythm Research Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Vascular Closure With Novel External Compression Device After Atrial Fibrillation Ablation: The LockeT Study
- Lead sponsor
- Kansas City Heart Rhythm Research Foundation
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 31, 2024
- Completion date
- December 31, 2024
- Enrollment
- 70 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation, hemostasis